A modeling study to inform screening and testing interventions for the control of SARS-CoV-2 on university campuses.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
15 03 2021
15 03 2021
Historique:
received:
03
09
2020
accepted:
22
02
2021
entrez:
16
3
2021
pubmed:
17
3
2021
medline:
30
3
2021
Statut:
epublish
Résumé
University administrators face decisions about how to safely return and maintain students, staff and faculty on campus throughout the 2020-21 school year. We developed a susceptible-exposed-infectious-recovered (SEIR) deterministic compartmental transmission model of SARS-CoV-2 among university students, staff, and faculty. Our goals were to inform planning at our own university, Emory University, a medium-sized university with around 15,000 students and 15,000 faculty and staff, and to provide a flexible modeling framework to inform the planning efforts at similar academic institutions. Control strategies of isolation and quarantine are initiated by screening (regardless of symptoms) or testing (of symptomatic individuals). We explored a range of screening and testing frequencies and performed a probabilistic sensitivity analysis. We found that among students, monthly and weekly screening can reduce cumulative incidence by 59% and 87%, respectively, while testing with a 2-, 4- and 7-day delay between onset of infectiousness and testing results in an 84%, 74% and 55% reduction in cumulative incidence. Smaller reductions were observed among staff and faculty. Community-introduction of SARS-CoV-2 onto campus may be controlled with testing, isolation, contract tracing and quarantine. Screening would need to be performed at least weekly to have substantial reductions beyond disease surveillance. This model can also inform resource requirements of diagnostic capacity and isolation/quarantine facilities associated with different strategies.
Identifiants
pubmed: 33723312
doi: 10.1038/s41598-021-85252-z
pii: 10.1038/s41598-021-85252-z
pmc: PMC7960702
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
5900Subventions
Organisme : NIAID NIH HHS
ID : R01 AI138783
Pays : United States
Organisme : NSF
ID : 2032084
Organisme : NIGMS NIH HHS
ID : R01 GM124280
Pays : United States
Organisme : NIH/NIAID
ID : 3R01AI143875-02S1
Organisme : NIH HHS
ID : R01 AI138783
Pays : United States
Références
PLoS Med. 2005 Jul;2(7):e174
pubmed: 16013892
Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S131-7
pubmed: 21342885
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
J Stat Softw. 2018 Apr;84:
pubmed: 29731699
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052846
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2825-30
pubmed: 21282645
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
J Adolesc Health. 2020 Dec;67(6):763-768
pubmed: 33071164
Math Biosci. 2020 Oct;328:108436
pubmed: 32758501
Clin Infect Dis. 2009 Dec 15;49(12):1811-20
pubmed: 19911964
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Nat Commun. 2021 Aug 17;12(1):5017
pubmed: 34404780
JAMA Netw Open. 2020 Jul 1;3(7):e2016818
pubmed: 32735339
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22430-22435
pubmed: 32820074
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Clin Infect Dis. 2009 Feb 1;48(3):292-8
pubmed: 19115970
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748